News

Mind Medicine: Initiating Hold Rating Due To Regulatory Challenges
Regulatory delays could hinder Mind Medicine's patient access and market entry. Read why we are initiating coverage on MNMD ...
The Island1d
Congratulations to Yuni Dewaraja, PhD, my little cousin
It gives me a great sense of pride and delight to write this. We all change as we traverse the pathway of our lives. I have ...
Optometry Advisor2d
High Dose Aflibercept Gets Priority Review for Retinal Vein Occlusion and Monthly Dosing
The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.
Penn Dental Medicine Study Finds New Therapy Shows Promise Against Periodontal Diseases
Periodontal diseases, commonly known as gingivitis and periodontitis, remain a significant global health challenge, affecting nearly 60% of adults aged 65 and older and contributing to substantial ...
Biogen Inc.: Leqembi? (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD) wh ...
Enhertu: Drug approved in the UK for advanced cancers. Here's what you need to know
A new cancer drug called trastuzumab deruxtecan, also known as Enhertu, has just been approved in the UK. This drug is ...